The representative top five genes reported in the newly diagnosed 37 GBM cases, including the primary surgery specimens, were TERT (65%), CDKN2A (57%), CDKN2B (51%), TP53(32%), and MTAP (43%). This evidence concerns the gene MTAP and glioblastoma.